What is the current market valuation of the US smart insulin-pens market?

The market valuation was $1014.3 Million in 2024. Read More

What is the projected market size for the US smart insulin-pens market by 2035?

The projected market size is $2670.0 Million by 2035. Read More

What is the expected CAGR for the US smart insulin-pens market during the forecast period 2025 - 2035?

The expected CAGR is 9.2% during the forecast period 2025 - 2035. Read More

Which companies are the key players in the US smart insulin-pens market?

Key players include Novo Nordisk, Sanofi, Boehringer Ingelheim, Roche, Medtronic, Insulet Corporation, Ypsomed, Eli Lilly and Company, and AstraZeneca. Read More

What are the main segments of the US smart insulin-pens market?

The main segments include Type, Technology, End User, and Distribution Channel. Read More

What was the valuation of smart insulin delivery devices in 2024?

The valuation of smart insulin delivery devices was $400.0 Million in 2024. Read More

How much is the market for diabetes type 2 patients valued at in 2024?

The market for diabetes type 2 patients was valued at $400.0 Million in 2024. Read More

What is the projected valuation for mobile app integration technology by 2035?

The projected valuation for mobile app integration technology is $970.0 Million by 2035. Read More

What was the market size for diabetes clinics as a distribution channel in 2024?

The market size for diabetes clinics as a distribution channel was $406.43 Million in 2024. Read More

What is the expected growth trend for smart insulin pens in the coming years?

The market appears to be on a growth trend, with a projected increase to $2670.0 Million by 2035. Read More

US Smart Insulin Pens Market

ID: MRFR/MED/12265-CR

100 Pages

Satyendra Maurya

Last Updated: January 29, 2026

US Smart Insulin Pens Market Research Report: Size, Share, Trend Analysis By Typess (Smart Insulin Pens, Smart Insulin Delivery Devices, Smart Monitoring Devices), By End Userss (Diabetes Type 1 Patients, Diabetes Type 2 Patients, Healthcare Facilities, Caregivers), By Technology (Bluetooth Enabled, Wireless, Connectivity, Mobile App Integration), By Distribution Channel (Online Pharmacies, Retail Pharmacies, Hospitals, Diabetes Clinics), Regions - Growth & Industry Forecast 2025 To 2035

US Smart Insulin Pens Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)9.2%

2024 Market Size$ 1,014.3 Million

2025 Market Size$ 1,107.62 Million

2035 Market Size$ 2,670 Million

Key Players

Novo Nordisk

Sanofi

Boehringer Ingelheim

Roche

Medtronic

Insulet Corporation

Trends

Technological Integration
Patient-Centric Design
Regulatory Support

Opportunities

Rising Diabetes Prevalence
Supportive Regulatory Environment
Growing Demand for Personalized Medicine

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Industrial Automation & Equipment, BY Type (USD Million)
  1. 4.1.1 Smart Insulin Pens
  2. 4.1.2 Smart Insulin Delivery Devices
  3. 4.1.3 Smart Monitoring Devices
2. 4.2 Industrial Automation & Equipment, BY Technology (USD Million)
  1. 4.2.1 Bluetooth Enabled
  2. 4.2.2 Wireless Connectivity
  3. 4.2.3 Mobile App Integration
3. 4.3 Industrial Automation & Equipment, BY End User (USD Million)
  1. 4.3.1 Diabetes Type 1 Patients
  2. 4.3.2 Diabetes Type 2 Patients
  3. 4.3.3 Healthcare Facilities
  4. 4.3.4 Caregivers
4. 4.4 Industrial Automation & Equipment, BY Distribution Channel (USD Million)
  1. 4.4.1 Online Pharmacies
  2. 4.4.2 Retail Pharmacies
  3. 4.4.3 Hospitals
  4. 4.4.4 Diabetes Clinics
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Industrial Automation & Equipment
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Industrial Automation & Equipment
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Novo Nordisk (DK)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Sanofi (FR)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Boehringer Ingelheim (DE)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Roche (CH)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Medtronic (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Insulet Corporation (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Ypsomed (CH)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Eli Lilly and Company (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 AstraZeneca (GB)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY TYPE
3. 6.3 US MARKET ANALYSIS BY TECHNOLOGY
4. 6.4 US MARKET ANALYSIS BY END USER
5. 6.5 US MARKET ANALYSIS BY DISTRIBUTION CHANNEL
6. 6.6 KEY BUYING CRITERIA OF INDUSTRIAL AUTOMATION & EQUIPMENT
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF INDUSTRIAL AUTOMATION & EQUIPMENT
9. 6.9 DRIVERS IMPACT ANALYSIS: INDUSTRIAL AUTOMATION & EQUIPMENT
10. 6.10 RESTRAINTS IMPACT ANALYSIS: INDUSTRIAL AUTOMATION & EQUIPMENT
11. 6.11 SUPPLY / VALUE CHAIN: INDUSTRIAL AUTOMATION & EQUIPMENT
12. 6.12 INDUSTRIAL AUTOMATION & EQUIPMENT, BY TYPE, 2024 (% SHARE)
13. 6.13 INDUSTRIAL AUTOMATION & EQUIPMENT, BY TYPE, 2024 TO 2035 (USD Million)
14. 6.14 INDUSTRIAL AUTOMATION & EQUIPMENT, BY TECHNOLOGY, 2024 (% SHARE)
15. 6.15 INDUSTRIAL AUTOMATION & EQUIPMENT, BY TECHNOLOGY, 2024 TO 2035 (USD Million)
16. 6.16 INDUSTRIAL AUTOMATION & EQUIPMENT, BY END USER, 2024 (% SHARE)
17. 6.17 INDUSTRIAL AUTOMATION & EQUIPMENT, BY END USER, 2024 TO 2035 (USD Million)
18. 6.18 INDUSTRIAL AUTOMATION & EQUIPMENT, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
19. 6.19 INDUSTRIAL AUTOMATION & EQUIPMENT, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY TECHNOLOGY, 2025-2035 (USD Million)
  3. 7.2.3 BY END USER, 2025-2035 (USD Million)
  4. 7.2.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Smart Insulin Pens Market Segmentation

US Smart Insulin Pens Market By Type (USD Million, 2025-2035)

Smart Insulin Pens
Smart Insulin Delivery Devices
Smart Monitoring Devices

US Smart Insulin Pens Market By Technology (USD Million, 2025-2035)

Bluetooth Enabled
Wireless Connectivity
Mobile App Integration

US Smart Insulin Pens Market By End User (USD Million, 2025-2035)

Diabetes Type 1 Patients
Diabetes Type 2 Patients
US Smart Insulin Pens Market Facilities
Caregivers

US Smart Insulin Pens Market By Distribution Channel (USD Million, 2025-2035)

Online Pharmacies
Retail Pharmacies
Hospitals
Diabetes Clinics

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”